
In addition, welcome, Maxime Meylan! Maxime Meylan started his PhD in November 2018 and will work on COLOSSUS within the INSERM team. He will contribute to the immuno-bioinformatics analysis for COLOSSUS. Within COLOSSUS, INSERM is involved in COLOSSUS Biorepository & Histopathology Analyses and will analyse the composition and functional orientation of the immune, fibroblastic and angiogenic tumour microenvironment.
*English translation: Integrated analysis and clinical impact of immune and stromal microenvironments in solid tumors